NCT02664883View on ClinicalTrials.gov

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

September 8, 2015

Primary Completion Date

April 13, 2022

Study Completion Date

October 29, 2025

Conditions
Healthy SubjectMetastatic Renal Cell CancerRecurrent Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell CancerStage III Renal Cell Cancer
Interventions
PROCEDURE

Computed Tomography

Correlative studies

OTHER

Cytology Specimen Collection Procedure

Undergo collection of blood and urine samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Magnetic Resonance Imaging

Correlative studies

Trial Locations (1)

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER

NCT02664883 - Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer | Biotech Hunter | Biotech Hunter